Magnetic vortex iron oxide nanorings coated with mesoporous silica as smart diagnostic and therapeutic nanoagents: Negative MRI-guided tumor magnetothermal-chemotherapy

Magnetic vortex iron oxide nanorings coated with mesoporous silica as smart diagnostic and therapeutic nanoagents: Negative MRI-guided tumor magnetothermal-chemotherapy Full article

Journal

Materials Today Communications
ISSN: 2352-4928

Output data

Year: 2025, Volume: 44, Article number : 111966, Pages count : 13 DOI: 10.1016/j.mtcomm.2025.111966

Authors

Wang Jing ¹ , Li Xueao ¹ , Zhao Wenqian ¹ , Tu Hui ¹ , Zu Xiangyang ¹ , Li Guangda ¹ , Li Jinghua ¹ , Li Jing ² , Zhuang Yuchuan ³ , Dong Yanbo ⁴ , Tulupov Andrey ⁵ , Zhang Fengshou ¹ , Bao Jianfeng ¹

Affiliations

1	School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China
2	Office of Science and Technology, Henan University of Science and Technology, Luoyang, China
3	Department of Imaging Sciences, University of Rochester Medical Center, Rochester 14627, USA
4	Faculty of Teacher Education, Pingdingshan University, Pingdingshan, Henan 467000, China
5	Laboratory of MRT technologies, The Institute International Tomography Center of the Russian Academy of Sciences, Institutskaya Str. 3A, Novosibirsk 630090, Russia

Encapsulated magnetic vortex iron oxide nanorings (MVIONs) within mesoporous silica (MVIONs@SiO2) have been developed to address key challenges in magnetic hyperthermia—specifically, controlled drug release and precise thermal management in tumor therapy. This study showcases the design of these nanoparticles for the targeted delivery of the chemotherapeutic agent doxorubicin (DOX), facilitated by alternating magnetic fields (AMF). The MVIONs@SiO2 nanoparticles exhibit exceptional specific absorption rates (SAR) of approximately 1021 W∙g−1, indicating high thermal efficiency that ensures effective tumor heating without harming surrounding tissues. Additionally, these nanoparticles achieve a DOX loading capacity of 23.4 % and a release rate of 60 % under magnetic heating conditions, optimizing drug delivery to the tumor site. The relaxation rate r2 of MVIONs@SiO2 is recorded at 53.32 mM−1s−1, demonstrating significant MRI contrast enhancement correlating with nanoparticle concentration within tumors. Experimental results from cell and animal studies confirm the biocompatibility and potent antitumor activity of MVIONs@SiO2, highlighting its dual function in improving chemotherapy and magnetic hyperthermia. This innovation in nanoparticle-based theranostics marks a significant advance in integrating diagnostic imaging and therapeutic heating, potentially revolutionizing cancer treatment and diagnostics.

Wang J. , Li X. , Zhao W. , Tu H. , Zu X. , Li G. , Li J. , Li J. , Zhuang Y. , Dong Y. , Tulupov A. , Zhang F. , Bao J.
Magnetic vortex iron oxide nanorings coated with mesoporous silica as smart diagnostic and therapeutic nanoagents: Negative MRI-guided tumor magnetothermal-chemotherapy
Materials Today Communications. 2025. V.44. 111966 :1-13. DOI: 10.1016/j.mtcomm.2025.111966 WOS Scopus

Web of science:	WOS:001434821500001
Scopus:	2-s2.0-85218455766

DB	Citing
Scopus	2
Web of science	2